IDiyas

For the Inventor, By the Inventor

Raleigh, NC, United States of America

David Lee Musso

USPTO Granted Patents = 15 

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • Durham, NC (US) (2009)
  • Research Triangle Park, NC (US) (2006 - 2014)
  • Raleigh, NC (US) (1992 - 2018)

Company Filing History:

goldMedal7 out of 281 
 
Glaxo Wellcome Inc.
 patents
silverMedal3 out of 2,198 
 
Smithkline Beecham Corporation
 patents
bronzeMedal2 out of 356 
 
Glaxosmithkline LLC
 patents
4. 1 out of 521 
 
Burroughs Wellcome Co.
 patents
5. 1 out of 12 
 
North Carolina Central University
 patents
6. 1 out of 1,269 
 
University of North Carolina at Chapel Hill
 patents
7. 1 out of 245 
 
Novartis Vaccines & Diagnostics, Gmbh
 patents
where one patent can have more than one assignee

Years Active: 1992-2018

Loading Chart...
15 patents (USPTO):Explore Patents
1. 10005720 - Compounds useful for the treatment of metabolic disorders and synthesis of the same (2018-06-26),
2. 8822518 - Compounds as antagonists or inverse agonists of opioid receptors for treatment of addiction (2014-09-02),
3. 8633175 - Compounds as antagonists or inverse agonists at opioid receptors (2014-01-21),
4. 7625909 - Substituted quinazolinone compounds (2009-12-01),
5. 7491731 - Crystal structure of liganded cFMS kinase domain (2009-02-17),
6. 7098206 - Pharmaceutically active morpholinol (2006-08-29),
7. 6391875 - Pharmaceutically active morpholinol (2002-05-21),
8. 6329400 - Formamide compounds as therapeutic agents (2001-12-11),
9. 6274579 - Pharmaceutically active morpholinol (2001-08-14),
10. 6191150 - Formamide compounds as therapeutic agents (2001-02-20),
11. 6124284 - Bicyclic amide derivatives and their use as muscle relaxants (2000-09-26),
12. 5872118 - Bicyclic amide derivatives and their use as muscle relaxants (1999-02-16),
13. 5719186 - Amide derivatives and their therapeutic use (1998-02-17),
14. 5708033 - Amide derivatives and their therapeutic use (1998-01-13),
15. 5104870 - Heterocyclic pharmaceutical compounds and use (1992-04-14),

Title: The Innovative Contributions of David Lee Musso

Introduction

David Lee Musso is a prominent inventor based in Raleigh, NC, known for his significant contributions to the field of pharmaceutical sciences. With a total of 15 patents to his name, Musso has made remarkable strides in developing compounds that address critical health issues, particularly metabolic disorders and addiction.

Latest Patents

Among his latest patents, Musso has developed compounds useful for the treatment of metabolic disorders. This invention provides compounds of Formula (I), wherein variables X, Y, Z, and R1 are defined. Some of these compounds act as glutamate dehydrogenase activators. Additionally, he has created compounds that serve as antagonists or inverse agonists of opioid receptors, aimed at treating addiction. These novel compounds are designed to interact with one or more opioid receptors and are accompanied by pharmaceutical compositions for their effective use.

Career Highlights

Musso has had a distinguished career, working with notable companies such as Glaxo Wellcome Inc. and SmithKline Beecham Corporation. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Musso has collaborated with esteemed colleagues, including James L. Kelley and Barrett R. Cooper. These partnerships have fostered innovation and have been instrumental in advancing his research endeavors.

Conclusion

David Lee Musso's innovative work in developing pharmaceutical compounds has made a significant impact on the treatment of metabolic disorders and addiction. His contributions continue to influence the field and pave the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…